Faculty of Dentistry, Cairo University
Cairo, Egypt
NCT Number: NCT07196683
The current study aims to assess the influence of different scaffolds on postoperative pain and success rate of pulpotomy in mandibular mature molars with symptomatic irreversible pulpitis
Trial opening soon.
Get Notified15 year–40 year
All sexes
Interventional
Not applicable
Cairo, Egypt
The study aims to assess different scaffolds used in regenerative pulpotomy of mature permanent mandibular first molars diagnosed with symptomatic irreversible pulpitis and their influence on postoperative pain and clinical and radiographic success rate of pulpotomy. It also aims to correlate the level of inflammatory mediators in pulpal blood to the success rate of pulpotomy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Regenerative pulpotomy combines the use of hydraulic calcium silicate based cements; MTA, together with biodegradable scaffolds such as PRF.
Other names: Vital pulp therapy, PRF pulpotomy
Time frame: 6, 12, 24, and 72 hours postoperatively
measured using numerical rating scale
Time frame: 1, 3, 6, 9 and 12 months postoperatively.
Based on clinical and radiographic signs and symptoms
Time frame: Upon access cavity preparation
Contact information is provided by the study sponsor or research team.
Cairo University
Other
Regenerative Potentials of Mature Mandibular First Molars With Symptomatic Irreversible Pulpitis Enhanced With Different Scaffolds: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07701551
Symptomatic Irreversible Pulpitis (SIP)
View Trial DetailsNCT07290049
Neurologic Manifestations, Pain
Fujairah, Emirate of Fujairah, United Arab Emirates
View Trial DetailsNCT07704463
Symptomatic Irreversible Pulpitis (SIP)
Alexandria, Egypt
View Trial DetailsNCT07697300
Symptomatic Irreversible Pulpitis (SIP)
Istanbul, Turkey (Türkiye)
View Trial Details